Cynata launches diabetic foot ulcer clinical trial

Clinical-stage stem cell and regenerative medicine company, Cynata Therapeutics has launched a ‘Phase I’ clinical trial on its Cymerus mesenchymal stem cell product used to treat diabetic foot ulcers, or “DFUs”, in humans. The company will now look to enrol 30 patients for the trial that…